![Kyle Carver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 763 841 $ al 31/08/2026
Kyle Carver worked at Kadmon Holdings, Inc. from 2014 to 2022, serving as Chief Accounting Officer & Controller from 2018 to 2022.
Mr. Carver completed undergraduate studies at Villanova University and earned an MBA from The Leonard N Stern School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVOMMUNE, INC. 0,17 % | 08/07/2026 | 60.335 ( 0,17 % ) | 763 841 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EVOMMUNE, INC. | Director Financiero/CFO | 01/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Comptroller/Controller/Auditor | 01/03/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
